Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $65.4700 (-0.09%) ($64.9200 - $65.5400) on Fri. Nov. 23, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.68% (three month average) | RSI | 64 | Latest Price | $65.4700(-0.09%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX declines -0.1% a day on average for past five trading days. | Weekly Trend | BAX advances 1.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(57%) SPLV(53%) VYM(52%) XLP(52%) IVE(49%) | Factors Impacting BAX price | BAX will decline at least -0.84% in a week (0% probabilities). TLT(-20%) DIA(-12%) GDXJ(-11%) VIXM(-10%) VXX(-9%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.84% (StdDev 1.68%) | Hourly BBV | 0 () | Intraday Trend | 0.8% | | | |
|
5 Day Moving Average | $65.34(0.2%) | 10 Day Moving Average | $64.51(1.49%) | 20 Day Moving Average | $64.41(1.65%) | To recent high | -15.8% | To recent low | 6.4% | Market Cap | $33.402b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |